Jan 14

Advocacy for Advancements: Patient Insight Influencing Action - 12:00 PM

{Video Available Now}

Let's take a step back. It's the New Year after a year unlike any we could have imagined! However, in the midst of the disruption and disaster wrought by COVID, the advocacy community has accomplished some great things. Join us on January 14th at the COVID Advocacy Exchange as we take stock of the year by discussing the accomplishments that did happen and consider what more we can do in 2021!

Brian Lee Director, Global Advocacy, CV, Fibrosis, MS and LCM, Bristol Myers Squibb
Maria Dutarte Coordinator, European Patients’ Academy (EUPATI)
Neil Bertelsen HTAi Patient and Citizen Involvement Group
Mellanie True Hills CSP, Founder and CEO, StopAfib.org
Dec 17

Building Stronger Relationships Across Healthcare Through Empathy - 12:00 PM

{Video Available Now}

As healthcare systems have increased in size, it has become difficult for patients, doctors and caregivers to have meaningful conversations. And … it can sometimes feel like physicians, patients and advocates, and industry all speak different languages. Throw in the intense pressure of the COVID pandemic and the lack of good communication between these groups can leave people pulling...

Shanelle Gabriel
Erin Galyean
Laura Adams
Sandra Leung
Nov 12

Taking Action to Correct Health Inequities - 12:00 PM

{Video Available Now}

The pandemic has brought the topic of health inequalities to the forefront of people’s minds across the globe. We live in an era where technology has made healthcare more available than ever before, and yet we struggle to deliver fair and equitable care to those who need it most. Now we have a chance to reassess and correct systemic imbalances in our health systems. What will we do with this...

John L. Damonti President, Bristol-Myers Squibb Foundation
Steven Kramer Deaf Community Representative
Patricia (Patti) Mae Doykos PhD, Lead, Health Equity Initiative and Director, BMS Foundation
Kristen D. Krause PhD, MPH Deputy Director, Center for Health, Identity, Behavior and Prevention Studies (CHIBPS)
Feyikemi (Kemi) Osundina PharmD, MS is an Associate Director of Oncology Advocacy at Bristol Myers Squibb (BMS)
Perry N. Halkitis PhD, MS, MPH, Dean, Professor of Urban-Global Public Health, and Director of Center for Health, Identity, Behavior and Prevention Studies (CHIBPS) at the Rutgers School of Public Health
Anthonise Louis Fields PhD Director, Strategic Collaborations, World Wide Medical Bristol Myers Squibb
Oct 14

Moving Forward and Rebuilding - 12:00 PM

{Video Available Now}

This year, COVID has presented all of us with many unknowns. As we continue navigating these challenging times, we could all use a little extra support. During this live session of the COVID Advocacy Exchange, keynote speaker Adam Grant will discuss moving forward and rebuilding, together. As an organizational psychologist, Adam...

Organizational Psychologist The Wharton School of Business Bestselling Author Host: WorkLife, a TED Original Podcast
PhD Executive Vice President Chief Commercialization Officer Bristol Myers Squibb
Oct 08

Getting Back to Work - 12:00 PM

{Video Available Now}

COVID has caused unprecedented disruption to the global economy, leaving millions of people without jobs, or a plan for how and when to return to work. While some companies have developed detailed strategies to maintain safety, many others do not have the means or infrastructure to invoke health screenings or social distancing rules. Compounding this, there has been little discussion of...

Tinamarie Duff Global Lead, BMS’s DAWN (Differently-Abled Workplace Network) People and Business Resource Group
Noreen Gleason Executive Director, Business Continuity and Corporate Event Response Team Lead, Bristol-Myers Squibb Company
Sep 10

Getting Back to Normal: Care by Putting Patients First - 12:00 PM

{Video Available Now}

If there is one positive thing that can be taken from the COVID pandemic, it is the opportunity to step back and reassess how our healthcare systems provide care. Whether uncovering areas for improvement, beginning to address health inequalities, or creating new opportunities for collaboration, COVID has demonstrated the strengths and weaknesses of our systems. As we return to treatment...

Dr. Nicholas A.J. Botwood BSc, MB BS, MRCP, MFPM
Jun 18

Telemedicine and Access to Care - 12:00 PM

{Video Available Now}

An important consequence of the global pandemic has been to greatly accelerate the use of telemedicine. While this development has enabled continued contact between patients and physicians during COVID, it has also exposed the pervasive inexperience of our medical systems with digital and virtual models of care. This session will bring together patients, physicians, and advocates to discuss...

Global PBRG (People & Business Resource Group) Lead, Bristol Myers Squibb
M.D., Chief Medical Officer, Bluestream Health
Lung Cancer survivor, Family Physician UW Medicine
MD MSc MBA PhD, Global Lead, OLA (Organization for Latino Achievement), Bristol Myers Squibb
M.D. Clinical Assistant Professor, Telemedicine Physician Lead, Interim Associate Program Director, Family Medicine Residency Program, Department of Family Medicine, Keck School of Medicine
Jun 11

Safely Returning to Clinical Trials - 12:00 PM

{Video Available Now}

Since the coronavirus pandemic started, clinical trial recruitment and enrollment is down 40-60% across therapeutic areas. As the quarantine period ends, we are left with many questions about how to safely move forward with research, especially for patients suffering from serious, life-threatening diseases that might increase their risk of dying from COVID-19. This session will bring together the...

Senior Vice President, Major Markets, Bristol-Myers Squibb
Executive Director, Partnerships and Digital Engagement, Syneos Health
Director, Science & Research, GO2 Foundation for Lung Cancer
PhD, MPH, Vice President of Research, LUNGevity Foundation
MD, PhD, MPH, Gastroenterologist, Tryon Medical Partners
Jun 04

Going Virtual: Best Practices for Advocacy Organizations - 12:00 PM

{Video Available Now}

A major change wrought by COVID is the transition to virtual communication. Advocacy organizations face the daunting task of restructuring their entire communication frameworks to meet this new reality. This session brings together experts from academia, advocacy, and industry to discuss how to build a virtual organization, run a virtual conference, and initiate virtual fundraising, so...

CEO, and CoFounder, GRYT Health
VP and Head of Global Digital Strategy, BMS
CEO, Lymphoma Coalition
Co-Founder and President, Elephants and Tea
May 28

Coalitions & Collaboration - 12:00 PM

{Video Available Now}

In a post-COVID world, advocacy organizations will face increased pressure to meet their mandates with fewer resources and fundraising capability. Coalitions offer a simple and effective way to pool resources, share information, improve problem-solving, and increase awareness. In this session, we will investigate the impact of coalitions on patient advocacy and explore best practices for forming...

CEO, The Max Foundation
CEO, Union for International Cancer Control (UICC)
MBE, Founder & Trustee, Arrhythmia Alliance, Founder & CEO, AF Association, Founder & CEO, STARS
May 21

Welcome & Introduction - 12:00 PM

{Video Available Now}

This is an unprecedented time for healthcare systems around the world. We, as patient advocates, are rushing to understand the impact on our communities and to figure out the best way to offer aid, resources, and support. This first session will focus on framing the problems that we all face so we can begin to tackle them together. Our panel will open the conversation by addressing...

CEO, and CoFounder, GRYT Health
Executive Director & Head, Global Advocacy, Bristol-Myers Squibb
Senior Vice President, Major Markets, Bristol-Myers Squibb
CEO, Fatty Liver Foundation
CO-Founder, Global Healthy Living Foundation (GHLF)
Partnerships & Programmes Director, World Heart Federation
Managing Director, Scientific Education Support (SES)